WELIPRED 125 is an injectable Methylprednisolone 125 mg corticosteroid formulation intended for situations requiring systemic anti-inflammatory or immunomodulatory therapy. Its rapid parenteral presentation makes it relevant to acute care, hospital and specialist practice across selected inflammatory, allergic and immune-mediated conditions. A specialized addition to the PCD Pharma Steroid & Injectable portfolio, with prescription-led positioning and emphasis on appropriate medical supervision.
Selected acute inflammatory, allergic and immune-mediated conditions requiring systemic corticosteroid treatment.
No, although it may sometimes be used alongside appropriate treatment when inflammation is significant.
Yes, particularly in susceptible patients or with higher doses.
Administer only under qualified medical supervision. The indication, dose and duration should be individualized according to clinical need. Monitor blood glucose, blood pressure, infection risk and other parameters when appropriate. Do not discontinue prolonged corticosteroid therapy abruptly without medical advice because adrenal suppression may occur after sustained treatment.
Possible adverse effects include increased blood glucose, fluid retention, mood changes, increased appetite, indigestion, insomnia and elevated blood pressure. Corticosteroids can reduce immune resistance and may mask symptoms of infection. With repeated or prolonged use, risks may include osteoporosis, adrenal suppression, weight gain and other systemic effects. Patients with diabetes, infection risk or other relevant conditions require appropriate monitoring.
WELIPRED 125: Methylprednisolone is a synthetic glucocorticoid that enters cells and interacts with glucocorticoid receptors, influencing gene transcription and reducing the production and activity of multiple inflammatory mediators. This suppresses excessive immune and inflammatory responses, helping reduce swelling, redness, tissue inflammation and related symptoms. Its injectable form provides systemic corticosteroid therapy when rapid or parenteral treatment is clinically required.
